Safety, immunogenicity and possible efficacy of immunochemotherapy of persistent Post Kala-azar Dermal Leishmaniasis

Simple item page
dc.contributor.authorMohamed, Ibrahim
dc.date.accessioned2015-03-16T11:53:33Z
dc.date.available2015-03-16T11:53:33Z
dc.date.issued2005
dc.descriptionThis paper had been presented for promotion at the university of Khartoum. To get the full text please contact the other at brahimelhassan@iend.orgen_US
dc.description.abstractPost kala-azar dermal leishmaniasis (PKDL) is a common skin condition that follows successful treatment of visceral leishmaniasis (VL) in Sudanese patients. Lesions persist for years in 15% of patients and are viewed as reservoirs for the disease. Drug treatment is protracted, toxic and costly. Cure is strongly correlated with conversion in the leishmanin skin test.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/7045
dc.publisherUniversity of Khartoumen_US
dc.subjectPKDL, Immunochemotherapy, alum/ALM+BCG candidate vaccineen_US
dc.titleSafety, immunogenicity and possible efficacy of immunochemotherapy of persistent Post Kala-azar Dermal Leishmaniasisen_US
dc.typeArticleen_US

Files

Collections

Medical and Health
Load more